Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

BACKGROUND: In recent years, several oral antidiabetic drugs with new mechanisms of action have become available, expanding the number of treatment options. Sodium/glucose cotransporter-2 (SGLT2) inhibitors are a new class of oral antidiabetic drugs with an insulin-independent mechanism promoting ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Watada, Hirotaka, Iwamoto, Yasuhiko, Utsunomiya, Kazunori, Terauchi, Yasuo, Tobe, Kazuyuki, Tanizawa, Yukio, Araki, Eiichi, Ueda, Masamichi, Suganami, Hideki, Watanabe, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021346/
https://www.ncbi.nlm.nih.gov/pubmed/24678906
http://dx.doi.org/10.1186/1475-2840-13-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021346/
https://www.ncbi.nlm.nih.gov/pubmed/24678906
http://dx.doi.org/10.1186/1475-2840-13-65

Ejemplares similares